Veterinary Drug terms — page 2 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

3-(3-Methylbut-2-en-1-yl)-3H-purin-6-amine 6-Amino-3-(Y,Y-dimethylallyl)-purine; 3H-Purin-6-amine, 3-(3-methyl-2-butenyl)-; 3-Isopentenyladenine
3-(4-Hydroxyphenyl)propionic acid 4-Hydroxybenzenepropanoic acid; Phloretic acid; 4-10-00-00631 (Beilstein Handbook Reference)
3-(Indol-3-yl)propionic acid 3-Indolepropionic acid; Indolepropionic acid; 5-22-03-00114 (Beilstein Handbook Reference)
3-Chlorophenol 3-Chlorophenol; 108-43-0; m-Chlorophenol; Phenol, 3-chloro-; Phenol, m-chloro-; 3-Hydroxychlorobenzene; m-Chlorophenic acid; meta-Chlorophenol; 3-Chloro-Phenol; NSC 59700; UNII-Z2Z7M2FTAD; 3-Chloro-1-hydroxybenzene; CCRIS 641; HSDB 1413; EINECS 203-582-6; Z2Z7M2FTAD; CHEMBL41172; AI3-23961; CHEBI:38855; HORNXRXVQWOLPJ-UHFFFAOYSA-N; MFCD00002256; 3-Chlorophenol, 99%; 3CH; m-chloro-phenol; 3-chloro phenol; m-Chlorophenol, solid; PubChem3677; m-Chlorophenol, liquid; 1li3; 3-Chlorophenol, 98%; CHLOROPHENOL(M-); ACMC-1C1IQ; DSSTox_CID_4800; WLN: QR CG; DSSTox_RID_77538; DSSTox_GSID_24800; SCHEMBL49772; KSC490K4H; UN 2020 (Salt/Mix); UN 2021 (Salt/Mix); DTXSID4024800; CTK3J0543; KS-00000WOI; ZINC404329; NSC59700; Tox21_200833; ANW-15941; BDBM50167952; LS-462; NSC-59700; SBB061136; STL183823; AKOS000118748; AS02833; CS-W020573; DB01957; MCULE-4606705291; PS-6042; RTR-001954; TRA0028192; NCGC00091698-01; NCGC00091698-02; NCGC00258387-01; CAS-108-43-0; SC-00300; 3-Chlorophenol 100 microg/mL in Methanol; DB-040829; ST2410654; TR-001954; FT-0615504; ST51047192; C14270; M-6257; 3-Chlorophenol, PESTANAL(R), analytical standard; Q3973362; W-108718; F0001-0169; m-Chlorophenol, liquid [UN2021] [Keep away from food]; m-Chlorophenol, solid [UN2020] [Keep away from food]; m-Chlorophenol, solid [UN2020] [Keep away from food]; Z1262246121; m-Chlorophenol, liquid [UN2021] [Keep away from food]; UNII-AZ1041M258 component HORNXRXVQWOLPJ-UHFFFAOYSA-N; UNII-E9JIO40PSX component HORNXRXVQWOLPJ-UHFFFAOYSA-N; InChI=1/C6H5ClO/c7-5-2-1-3-6(8)4-5/h1-4,8; AI3-23961
3-Hydroxyanthranilic acid 2-Amino-3-hydroxybenzoic acid; 2-Amino-3-hydroxy-benzoic acid; 4-14-00-02071 (Beilstein Handbook Reference)
3-Hydroxypropionaldehyde 3-Hydroxypropanal; 3-Hydroxypropanal; 2134-29-4; 3-Hydroxypropionaldehyde; Propanal, 3-hydroxy-; Reuterin; beta-Hydroxypropionaldehyde; hydracrylaldehyde; hydroxypropionaldehyde; UNII-S5F79YAO6U; S5F79YAO6U; 3-oxo-1-propanol; Hydracrolein; b-Hydroxypropanal; beta-Hydroxypropanal; b-Hydroxypropionaldehyde; 3-hydroxy-propionaldehyde; AMOT0353; DTXSID4062199; CHEBI:17871; CTK1A3030; AKXKFZDCRYJKTF-UHFFFAOYSA-N; ZINC1532803; EINECS 218-365-1; AKOS007930810; AM85663; GS-0048; 3-Hydroxypropanal (1M solution in water); C00969; Reuterin (3-Hydroxypropanal), 1M aqueous solution; Q7317628; 3-Hydroxypropionaldehyde; EINECS 218-365-1
3-Iodo-L-tyrosine 3-Iodotyrosine; 3-Iodo-L-tyrosine; 70-78-0; H-Tyr(3-I)-OH; 3-IODOTYROSINE; L-Tyrosine, 3-iodo-; 3-IODO-TYROSINE; (S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoic acid; Monoiodotyrosine; 3-Monoiodo-L-tyrosine; IODOTYROSINE; 3-Iodo-4-hydroxyphenylalanine; (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid; UNII-FRQ98U4U27; Tyrosine, 3-iodo-; H-3-Iodo-Tyr-OH; MLS000069664; FRQ98U4U27; CHEBI:27847; UQTZMGFTRHFAAM-ZETCQYMHSA-N; MFCD00002608; SMR000059143; I-7700; 3-Iodo-L-tyrosine, 97%; C9H10INO3; IYR; AK-86417; EINECS 200-744-8; L-Tyrosine-3-iodo; IOTYROSINE; NSC 210787; H-Tyr(3-l)-OH; bmse000337; Tyrosine, 3-iodo-, L-; Lopac0_000673; KSC223I7D; 4-Hydroxy-3-iodophenylalanine; SCHEMBL159412; 3-Iodo-L-tyrosine (I-Tyr); CHEMBL479789; cid_439744; ZINC1575; DTXSID1075353; L-Tyrosine, 3-iodo- (9CI); BDBM37633; CTK1C3471; 4-Hydroxy-3-iodophenylalanine #; ZX-AFC003197; HMS3262G07; ACT02993; EBD12375; KS-00000MM1; Tyrosine, 3-iodo-, L- (8CI); Tox21_500673; ANW-35953; CI-043; KM1371; S(-)-3-Iodo-4-hydroxyphenylalanine; s6044; SBB069112; AKOS015919312; AC-7495; AM83577; CCG-204759; CS-W008452; DB01758; FCH3512538; HY-W008452; LP00673; RTR-023384; SDCCGSBI-0050652.P002; NCGC00022269-03; NCGC00022269-04; NCGC00022269-05; NCGC00261358-01; AS-18515; CC-15382; 3-Iodo-L-tyrosine, >=99.0% (HPLC); AX8006619; ST2414589; TR-023384; EU-0100673; FT-0615918; I0075; ST51005934; W8001; C02515; I 8250; M06129; 002T608; C-19077; Q410703; SR-01000075606; SR-01000075606-1; (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoate; (2S)-2-amino-3-(4-hydroxy-3-iodo-phenyl)propionic acid; (2S)-2-azanyl-3-(3-iodanyl-4-oxidanyl-phenyl)propanoic acid; 1E933C28-2631-4076-821D-3F47E9A1B023; EINECS 200-744-8
3-Isobutyl-1-methylxanthine 3,9-dihydro-1-methyl-3-(2-methylpropyl)-1H-Purine-2,6-dione; 1-Methyl-3-isobutylxanthine; CCRIS 4290
3-Methylcatechol 3-Methyl-1,2-benzenediol; 3-methylcatechol; 3-methylbenzene-1,2-diol; 488-17-5; 2,3-dihydroxytoluene; 3-Methylpyrocatechol; 2,3-Toluenediol; 1,2-Benzenediol, 3-methyl-; 3-Methyl-1,2-benzenediol; Dihydroxytoluene; Pyrocatechol, 3-methyl-; Catechol, 3-methyl-; 1,2-Dihydroxy-3-methylbenzene; 3-Methyl-1,2-dihydroxybenzene; 3-METHYL CATECHOL; UNII-0HUZ4Q9R8C; 3-METHYL-BENZENE-1,2-DIOL; NSC 66523; EINECS 207-672-6; BRN 0774602; 0HUZ4Q9R8C; AI3-61047; CHEBI:18404; PGSWEKYNAOWQDF-UHFFFAOYSA-N; Methyl Catechol; 2, 3-Toluenediol; PubChem17861; 3-Methylcatechol, 98%; 2-Hydroxy-3-methylphenol; ACMC-209ke4; bmse000334; 1,2-Benzenediol, methyl-; WLN: QR BQ C1; SCHEMBL67369; 2,3-Dihydroxytoluene polymer; 4-06-00-05860 (Beilstein Handbook Reference); KSC191O0F; CHEMBL1173328; DTXSID9060071; SCHEMBL10526382; 1, 2-Dihydroxy-3-methylbenzene; 3-Methyl-1, 2-dihydroxybenzene; 3-methyl-1,2-dihydroxy benzene; CTK0J1702; KS-00000NOE; HMS1789D12; NSC66523; STR09012; ANW-30698; MFCD00016435; NSC-66523; SBB055151; ZINC13512198; AKOS000121356; CS-W013531; DB03454; MCULE-5410704360; VZ35148; 28930-19-0; 4CN-2507; AC-22587; AK-76819; AM808211; SC-15269; DB-028549; LS-136442; RT-002271; ST2417803; FT-0081670; FT-0612043; M0184; ST50409862; X8309; C02923; M-4309; W-106038; Q15303191; Z56347229; F0001-1277; InChI=1/C7H8O2/c1-5-3-2-4-6(8)7(5)9/h2-4,8-9H,1H; 3-Methylcatechol; 4-06-00-05860 (Beilstein Handbook Reference)
3-Methylpyridine 3-METHYLPYRIDINE; 3-Picoline; 108-99-6; beta-Picoline; Pyridine, 3-methyl-; m-Picoline; m-Methylpyridine; B-Picoline; beta-Methylpyridine; 3-Methyl pyridine; .beta.-Methylpyridine; NSC 18251; .beta.-Picoline; UNII-B083J4KF7F; 3-Mepy; CCRIS 1722; HSDB 4254; EINECS 203-636-9; AI3-24110; 3-Methylpyridin; B083J4KF7F; CHEBI:39922; ITQTTZVARXURQS-UHFFFAOYSA-N; 3-Picoline, 99%; DSSTox_CID_1897; DSSTox_RID_76391; DSSTox_GSID_21897; meta-Methylpyridine; CAS-108-99-6; 3-methypyridine; 5-methylpyridine; 3-methyl pyridin; 3-methyl-pyridine; MFCD00006402; 3-Methylpyridine, 99%; BETA METHYL PYRIDINE; EC 203-636-9; NCIOpen2_004641; KSC176I9F; MLS001065607; CHEMBL15722; ACMC-20991u; 3-Picoline, analytical standard; 3-Methylpyridine, >=99.5%; DTXSID9021897; CTK0H6492; KS-00000WRJ; HMS3039L05; BCP22897; BCP26368; NSC18251; ZINC8294958; Tox21_201966; Tox21_303001; ANW-16000; LS-478; NSC-18251; STL282747; AKOS000119862; ZINC328577986; AM81278; DB01996; MCULE-7651055603; RTR-007635; NCGC00091447-01; NCGC00091447-02; NCGC00256559-01; NCGC00259515-01; SC-15292; SMR000568465; m-Picoline [UN2313] [Flammable liquid]; DB-016018; m-Picoline [UN2313] [Flammable liquid]; FT-0616178; P0416; ST24042357; 177484-EP2277864A1; 177484-EP2280002A1; 177485-EP2277878A1; 177485-EP2280002A1; 177486-EP2277864A1; 177486-EP2280002A1; Q2697560; W-108710; F0001-0187; InChI=1/C6H7N/c1-6-3-2-4-7-5-6/h2-5H,1H; 5HS; AI3-24110
3-Octylthio-1,1,1-trifluoro-2-propanone 1,1,1-Trifluoro-3-(octylthio)-2-propanone; 3-Octylthio-1,1,1-trifluoro-2-propanone; 3-Otfp
3-Phenylbutyric acid beta-Methylbenzenepropanoic acid; 3-Phenylbutyric acid; AI3-11112
3-Phenylpropylamine Benzenepropanamine; 3-Phenylpropylamine; 3-phenylpropan-1-amine; 2038-57-5; Benzenepropanamine; 1-Amino-3-phenylpropane; Hydrocinnamylamine; 3-Phenyl-n-propylamine; 3-Phenyl-1-propylamine; gamma-Phenylpropylamine; 3-Phenyl-1-propanamine; PROPYLAMINE, 3-PHENYL-; 3-phenylpropanamine; gamma-Phenyl-n-propylamine; 3-Phenyl-propylamine; phenylpropylamine; NSC 87080; UNII-P8326EZ31P; 3-Phenyl-1-aminopropane; .gamma.-Phenylpropylamine; EINECS 218-012-1; MFCD00008224; BRN 2205526; .gamma.-Phenyl-n-propylamine; CHEMBL276864; 3-Phenyl-1-propylamine, 98%; LYUQWQRTDLVQGA-UHFFFAOYSA-N; P8326EZ31P; Benzenepropanamine, hydrochloride; phenylpropyl amine; 1tnk; 1utl; 3-Phenylproylamine; 3-aminopropylbenzene; 3-phenylpropylarnine; 3-phenylpropyl-amine; (3-phenylpropyl)amine; 3-phenyl propyl amine; 3-phenyl-propyl-amine; gamma-Aminopropylbenzene; 1-phenyl-3-propylamine; ACMC-1CLGX; Benzenepropanamine (9CI); NCIOpen2_001106; SCHEMBL52482; 4-12-00-02625 (Beilstein Handbook Reference); DTXSID10174307; KS-000013BE; NSC87080; ZINC1561633; 0451AB; ANW-24053; BBL005325; BDBM50113826; NSC-87080; SBB028248; STK825996; AKOS000120432; AB00940; DB04410; MCULE-1006208888; PS-5335; RTR-009506; TRA0033806; SC-65438; AB0062715; DB-045192; LS-125732; TR-009506; BB 0216505; FT-0616351; H2535; P0664; ST51038620; EN300-20467; 12061-EP2280001A1; 12061-EP2316828A1; J-013266; Q23978199; F2190-0400; Z1245664622; InChI=1/C9H13N/c10-8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8,10H; 3-Phenylpropylamine; 4-12-00-02625 (Beilstein Handbook Reference)
3-Phosphonopropionic acid 3-Phosphonopropanoic acid; beta-Phosphonopropionic acid; EINECS 227-738-8
3-Pyridinecarboxamide nicotinamide; niacinamide; 98-92-0; 3-Pyridinecarboxamide; Nicotinic acid amide; pyridine-3-carboxamide; vitamin PP; Papulex; Aminicotin; Amixicotyn; Nicobion; Nicotylamide; Nikotinamid; Savacotyl; Benicot; Dipegyl; Endobion; Hansamid; Pelmine; Nicotinic amide; Delonin amide; Pelonin amide; Vi-Nicotyl; Austrovit PP; Inovitan PP; Vitamin B; Nicosylamide; Nicotilamide; Nicotililamido; Amnicotin; Niacevit; Nicamina; Nicamindon; Nicofort; Nicomidol; Nicotamide; Nicovitina; Nicovitol; Nicozymin; Niocinamide; Niozymin; Niamide; Nicasir; Nicogen; Nicota; Nicotol; Nicovit; Niko-tamin; 3-Carbamoylpyridine; Nicotine acid amide; Nandervit-N; Pyridine-3-carboxylic acid amide; Niavit PP; Nicosan 2; Nicotine amide; beta-Pyridinecarboxamide; Nikotinsaeureamid; Nicotylamidum; Mediatric; Nicotinsaureamid; Pyridine, 3-carbamoyl-; Nicotinamidum; m-(Aminocarbonyl)pyridine; Acid amide; Factor pp; 3-Pyridinecarboxylic acid amide; Nicotinamida; Nicovel; Vitamin B (VAN); Pelmin; Amid kyseliny nikotinove; Witamina PP; PP-Faktor; Amide PP; Nicotinsaureamid [German]; Nikotinsaeureamid [German]; Amid kyseliny nikotinove [Czech]; Nicotinamidum [INN-Latin]; Nicotinamida [INN-Spanish]; NAM; Niacinamide [USAN]; Nictoamide; CCRIS 1901; Dipigyl; HSDB 1237; Vi-noctyl; AI3-02906; Nicotinamide (Vitamin B3); NSC 13128; C6H6N2O; b-Pyridinecarboxamide; Niacinamide [USP]; UNII-25X51I8RD4; EINECS 202-713-4; 3-(aminocarbonyl)pyridine; .beta.-Pyridinecarboxamide; CHEMBL1140; MLS000069714; DEA No. 1405; CHEBI:17154; DFPAKSUCGFBDDF-UHFFFAOYSA-N; 25X51I8RD4; NSC13128; Niacinamide (USP); MFCD00006395; NSC-13128; NSC-27452; Nicotinamide, 99%; NCGC00093354-03; NCGC00093354-05; SMR000058212; DSSTox_CID_929; WLN: T6NJ CVZ; DSSTox_RID_75873; DSSTox_GSID_20929; Enduramide; CAS-98-92-0; B3, Vitamin; Vitamin B 3; B 3, Vitamin; 3 Pyridinecarboxamide; SR-01000721872; Nicotinsaureamid Jenapharm; Jenapharm, Nicotinsaureamid; Niacotinamide; Nicotinamid; nicotin-amide; Nicotinsaeureamid; 3-Amidopyridine; Nicotinamide,(S); Vitamin B3 amide; 3-yridinecarboxamide; Nicotinamide [INN]; ACMC-20aizz; Mediatric (Salt/Mix); niacin - Vitamin B3; 1yc5; Opera_ID_775; Niacinamide(Vitamin B3); bmse000281; MolMap_000061; EC 202-713-4; SCHEMBL2926; Nicotinamide (JP17/INN); KSC237G2T; MLS001424246; SCHEMBL6278767; SGCUT00176; ZINC5878; Niacinamide; Nicotinic acid amide; DTXSID2020929; SCHEMBL19978192; BDBM27507; Nicotinamide, niacin, vitamin B3; HMS2052M21; HMS2090B05; HMS2093H03; HMS2236J03; HMS3370F21; HMS3394M21; HMS3655M20; HMS3713B22; Pharmakon1600-01505397; BCP07322; HY-B0150; NSC27452; to_000073; Nicotinamide 1.0 mg/ml in Methanol; Nicotinamide, >=98.5% (HPLC); Nicotinamide, >=99.5% (HPLC); Tox21_111202; Tox21_201716; Tox21_302776; ANW-75549; BBL013003; NSC759115; s1899; SBB004283; STL163867; AKOS005715850; Tox21_111202_1; CCG-101149; CS-1968; DB02701; LS-2051; MCULE-3532732201; NC00399; NSC-759115; RTC-066615; TRA0056599; Nicotinamide 100 microg/mL in Methanol; Nicotinamide, >=98% (HPLC), powder; NCGC00093354-04; NCGC00093354-06; NCGC00093354-09; NCGC00256432-01; NCGC00259265-01; AS-13845; CPD000058212; K774; Nicotinamide, puriss., 99.0-101.0%; SAM001246860; SC-18039; Nicotinamide, tested according to Ph.Eur.; SBI-0206826.P001; AB2000359; DB-057754; ST2419748; TC-066615; FT-0631517; N0078; N1651; ST51037366; SW197779-3; EN300-15612; Niacinamide, meets USP testing specifications; 3418-EP2281816A1; 3418-EP2281818A1; 3418-EP2285778A1; 3418-EP2287165A2; 3418-EP2295424A1; 3418-EP2307377A1; 3418-EP2307378A1; 3418-EP2308858A1; 3418-EP2308874A1; 3418-EP2311808A1; 3418-EP2311829A1; C00153; D00036; J10422; Nicotinamide (Niacinamide), analytical standard; W-3583; 11783-EP2269610A2; 11783-EP2289510A1; 11783-EP2316457A1; 11783-EP2316458A1; 11783-EP2316825A1; 11783-EP2316826A1; 11783-EP2316827A1; 11783-EP2316828A1; AB00373895-13; AB00373895_15; AB00373895_16; Nicotinamide, Vetec(TM) reagent grade, >=98%; A845925; AC-907/25014114; Q192423; Q-201470; SR-01000721872-3; SR-01000721872-4; SR-01000721872-5; Z33546463; F2173-0513; Niacinamide; Nicotinic acid amide; Vitamin B3; Vitamin PP; Nicotinamide, British Pharmacopoeia (BP) Reference Standard; A186B02E-6C70-4E54-9739-79398D439AAA; Nicotinamide, European Pharmacopoeia (EP) Reference Standard; Niacinamide, United States Pharmacopeia (USP) Reference Standard; InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9; Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material; Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture; Nicotinamide (Vitamin B3) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Niacinamide; AI3-02906
3-Selenyl-L-alanine SELENOCYSTEINE; L-selenocysteine; 3-selenyl-L-alanine; L-Selenocystein; L-Selenozystein; (2R)-2-amino-3-selanylpropanoic acid; UNII-0CH9049VIS; 0CH9049VIS; CHEBI:16633; (R)-2-Amino-3-hydroselenopropanoic acid; (2R)-2-amino-3-selanylpropanoate; seleno-cysteine; 3-seleno-alanine; SCHEMBL38518; CHEMBL109962; DTXSID00881371; AKOS025146617; DB02345; 236S585; Selenocysteine; UNII-0CH9049VIS
3[N-Morpholino]propane sulphonic acid 4-Morpholinepropanesulfonic acid; MOPS; BRN 1106776
4,4'-Dihydroxybenzophenone Bis(4-hydroxyphenyl)methanone; 4,4'-Dihydroxybenzophenone; 611-99-4; bis(4-hydroxyphenyl)methanone; HBP (ketone); Methanone, bis(4-hydroxyphenyl)-; 4,4'-dihydoxy-benzophenone; Bis(4-hydroxyphenyl) ketone; Bis(p-hydroxy)benzophenone; 4,4'-Dihydroxydiphenyl ketone; p,p'-Dihydroxybenzophenone; Benzophenone, 4,4'-dihydroxy-; UNII-HZR7D31SBY; 4,4'-Dihydoxybenzophenone; NSC 2831; MFCD00002358; 4,4'-dihydroxy benzophenone; EINECS 210-288-1; HZR7D31SBY; BRN 1874572; AI3-00127; CHEBI:34365; Bis-(4-hydroxy-phenyl)-methanone; RXNYJUSEXLAVNQ-UHFFFAOYSA-N; 4,4-DIHYDROXY BENZOPHENONE; AK-47331; di4-hydroxyphenyl ketone; W-105181; 4,4'-Dihydroxybenzophenone, 97%; 4,4'-dihydroxybenzophenon; 4-(4-hydroxybenzoyl)phenol; CCRIS 9457; PubChem3398; 4,4'dihydroxybenzophenone; ACMC-1B0VI; DSSTox_CID_2425; 4,4' dihydroxybenzophenone; 4,4'dihydroxy-benzophenone; 4,4 -Dihydroxybenzophenone; 4,4-Dihydroxybenzophenone; DSSTox_RID_76587; 4,4'-dihydroxy-benzophenone; DSSTox_GSID_22425; Oprea1_287266; SCHEMBL18423; 4,4''-Dihydroxybenzophenone; 4,4'-Dihydroxybenzophenone; 4-08-00-02452 (Beilstein Handbook Reference); BIDD:ER0179; bis(4-hydroxyphenyl)-methanone; CHEMBL194859; DTXSID1022425; 4,4'-DHBP; BDBM25807; TIMTEC-BB SBB000543; ZINC28449; NSC2831; 4,4'-Dihydroxybenzophenone, 99%; KS-00000C0X; NSC-2831; Tox21_200550; 4-[(4-hydroxyphenyl)carbonyl]phenol; AC-348; ANW-33720; Compound 0627-0373 (DHBP); LABOTEST-BB LT00159523; SBB000543; STK668062; AKOS005206702; AS02437; CS-W014942; DB07635; GS-3450; LS11724; MCULE-2438326501; TRA0008959; NCGC00248695-01; NCGC00258104-01; BR-47331; CAS-611-99-4; CC-17151; LS-38905; Methanone, bis(4-hydroxyphenyl)- (9CI); SC-05725; ST041020; SY005681; AB0011053; AX8034292; DB-014392; TC-122465; AM20050154; D0577; FT-0617057; ST24032673; 4,4'-Dihydroxybenzophenone, analytical standard; C14220; M-4866; 611D994; C-11340; SR-01000393027; 4,4 inverted exclamation mark -Dihydroxybenzophenone; Q4637052; SR-01000393027-1; 4,4'-Dihydoxy-benzophenone; 4-08-00-02452 (Beilstein Handbook Reference)
4-(4-Fluorophenyl)-2-(4-methylsulphinylphenyl)-5-(4-pyridyl)-1H-imidazole 4-[5-(4-Fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-4-yl]pyridine; SB-203580; SB 203580
4-(Diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]piperidine HQL-79; 162641-16-9; HQL 79; 1-(3-(1H-tetrazol-5-yl)propyl)-4-(benzhydryloxy)piperidine; 4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE; CHEMBL574003; 4-(diphenylmethoxy)-1-[3-(1h-tetrazol-5-yl)propyl]piperidine; 2cvd; HQL79; TZQGXAHOROZEKN-UHFFFAOYSA-N; SCHEMBL347141; GTPL6662; HQL-97; AOB1729; DTXSID50424898; EX-A091; SYN5073; HMS3648E13; BCP06026; ZINC3810035; BDBM50300128; AKOS024457666; AKOS032947265; AM84555; DB07917; NCGC00343938-06; 4CA-0621; AS-16439; CC-16812; HQL; ZINC000003810035; DB-043530; HY-108259; B7421; CS-0027831; FT-0643573; Z-3132; C-35640; SR-01000946205; J-009960; SR-01000946205-1; Q27077992; 1-(3-(2H-tetrazol-5-yl)propyl)-4-(benzhydryloxy)piperidine; 4-(Diphenylmethoxy)-1-(3-2H-tetrazol-5-yl)propyl]-piperidine; 4-(Diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propylpiperidine; 4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]piperidine; 4-(Diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl] piperidine; 4-[di(phenyl)methoxy]-1-[3-(2H-tetrazol-5-yl)propyl]piperidine; Piperidine, 4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]-; Piperidine,4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]-; 4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE
4-Acetamidobenzenesulphonamide N-[4-(Aminosulfonyl)phenyl]acetamide; 4-Acetamidobenzenesulfonamide; 121-61-9; N-(4-Sulfamoylphenyl)acetamide; N4-ACETYLSULFANILAMIDE; Acetylsulfanilamide; Neotherapol; p-Sulfamylacetanilide; Erytrin; 4'-Sulfamylacetanilide; 4-Acetylaminobenzenesulfonamide; N4-Acetsulfanilamide; 4'-Sulfamoylacetanilide; Sulfanilamide-N4-acetate; p-Sulfamoylacetanilide; p-Acetamidobenzenesulfonamide; N'-Acetylsulphanilamide; 4'-Sulphamoylacetanilide; Benzenesulfonamide, p-acetamido-; N-(4-Sulphamoylphenyl)acetamide; p-(Acetylamino)benzenesulfonamide; Acetamide, N-[4-(aminosulfonyl)phenyl]-; Acetanilide, 4'-sulfamoyl-; Benzenesulfonamide, 4-(acetylamino)-; N-4-Acetylsulfanilamide; NSC 217; A-319; N(sup 4)-Acetsulfanilamide; N(sup 4)-Acetylsulfanilamide; N-(4-Sulfamylphenyl)acetamide; CCRIS 6813; Sulfanilamide-N(sup 4)-acetate; UNII-340484WZ3L; EINECS 204-486-7; N-(4-(Aminosulfonyl)phenyl)acetamide; N-[4-(Aminosulfonyl)phenyl]acetamide; CHEMBL687; BRN 0746675; Acetamide, N-(4-(aminosulfonyl)phenyl)-; AI3-08023; Acetsulphanilamide; N-(4-Sulfamoyl-phenyl)-acetamide; PKOFBDHYTMYVGJ-UHFFFAOYSA-N; 340484WZ3L; Acetylsulfamine; Acetylsulphanilamide; N-[4-(aminosulfonyl)phenyl]-Acetamide; Sulfanilamide-N-acetyl; PubChem13328; N4 -acetylsulfanilamide; ACMC-209aeq; Enamine_001217; Cambridge id 5152132; DSSTox_CID_21529; DSSTox_RID_79768; N4-ACETYL METABOLITE; DSSTox_GSID_41529; Oprea1_094374; Oprea1_582774; 4-Acetamido-benzenesulfonamide; SCHEMBL359721; aromatic sulfonamide compound 8; NSC217; 4-N-Acetylaminophenylsulfonamide; DTXSID4041529; BDBM16643; CTK4B2552; PKOFBDHYTMYVGJ-UHFFFAOYSA-; NSC-217; HMS1397H07; ZINC134036; Tox21_300850; 7900AF; ANW-17760; NSC406839; SBB016985; STL308440; AKOS000141336; MCULE-8661643137; NSC-406839; PS-4449; SDCCGMLS-0064665.P001; Acetamide,N-[4-(aminosulfonyl)phenyl]-; N-[4-(Aminosulfonyl)phenyl]acetamide #; NCGC00248191-01; NCGC00254753-01; CAS-121-61-9; LS-10827; SC-57988; DB-061940; TC-106505; A0115; CS-0080221; FT-0647475; ST50168205; A18135; K-1622; Acetamide, N-(4-(aminosulfonyl)phenyl)- (9CI); W-108453; Q27256303; Z27682721; InChI=1/C8H10N2O3S/c1-6(11)10-7-2-4-8(5-3-7)14(9,12)13/h2-5H,1H3,(H,10,11)(H2,9,12,13); N4-Acetylsulfanilamide; A-319
4-Acetamidobenzoic acid p-Acetamidobenzoic acid; Acedoben; Acedoben [INN-Spanish]
4-Amino-1,8-naphthalimide 6-Amino-1H-benz[de]isoquinoline-1,3(2H)-dione; 4-Amino-1,8-naphthalimide; 4-22-00-06603 (Beilstein Handbook Reference)
4-Amino-5-hydroxymethyl-2-methylpyrimidine 4-Amino-2-methyl-5-pyrimidinemethanol; 73-67-6; (4-Amino-2-methyl-5-pyrimidinyl)methanol; Toxopyrimidine; (4-amino-2-methylpyrimidin-5-yl)methanol; 4-amino-5-hydroxymethyl-2-methylpyrimidine; pyramin; Atoxopyrimidine; Pyrazan; OMPM; 4-amino-2-methyl-5-pyrimidinemethanol; 5-Pyrimidinemethanol, 4-amino-2-methyl-; Oxymethylpyrimidine; Pyramine (VAN); Pyramin (VAN); 2-Methyl-4-amino-5-hydroxymethylpyrimidine; UNII-G62V17J09J; 2-M-4-A-5-Hmp; hydroxymethylpyrimidine; NSC 28247; Oprea1_032125; Pyramine (thiamine metabolite); 4-amino-2-methyl-5-hydroxymethylpyrimidine; CHEBI:16892; EC-000.1414; G62V17J09J; NSC28247; DB02022; TXP; 5-Pyrimidinemethanol,4-amino-2-methyl-; C01279; HMH; 5-Pyrimidinemethanol, 4-amino-2-methyl- (8CI)(9CI); SCHEMBL479344; NChemBio.2007.13-comp6; CTK5D8458; KS-00000NXP; DTXSID80223275; VUTBELPREDJDDH-UHFFFAOYSA-N; ZINC895559; ANW-52412; BBL100129; NSC-28247; STK374214; ZINC00895559; AKOS002676258; 2-Methyl-4-aminopyrimidine-5-methanol; 4-Amino-2-methylpyrimidine-5-methanol; CS-W006265; MCULE-7050395274; 4amino-5-hydroxymethyl-2-methylpyrimidine; AK-29486; BBV-00026439; BR-29486; DS-11140; SC-70703; (4-Amino-2-methyl-pyrimidin-5-yl)methanol; 2-methyl-4-amino-5-hydroxylmethylpyrimidine; 6-amino-5-hydroxymethyl-2-methylpyrimidine; AB0026493; DB-005507; ST1141009; TR-032649; 4CH-001566; FT-0081373; FT-0647258; ST50900257; W8173; (4-amino-2-methylpyrimidin-5-yl)methan-1-ol; A19113; S-6735; J-501348; Q27093111; Z1741975280; Toxopyrimidine; Atoxopyrimidine
4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulphonamide sulfamonomethoxine; 1220-83-3; Sulfamonomethoxin; Daimeton; Sulfamonometoxi4-amino-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide; Sulfamonomethoxinum; Benzenesulfonamide, 4-amino-N-(6-methoxy-4-pyrimidinyl)-; DS-36; 4-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide; DJ-1550; N1-(6-Methoxy-4-pyrimidinyl)sulfanilamide; ICI 32525; Ro 4-3476; Sulfamonomethoxinum [INN-Latin]; Sulfamonometoxina [INN-Spanish]; UNII-U700P169W2; 4-METHOXY-6-SULFANILAMIDOPYRIMIDINE; 4-amino-N-(6-methoxypyrimidin-4-yl)benzene-1-sulfonamide; BRN 0621128; Sulfamonomethoxine [USAN:INN:BAN:JAN]; CHEBI:32164; U700P169W2; NCGC00016572-01; CAS-1220-83-3; Daimeton (TN); DSSTox_CID_25351; DSSTox_RID_80818; DSSTox_GSID_45351; N(sup 1)-(6-Methoxy-4-pyrimidinyl)sulfanilamide; Sulfanilamide, N(sup 1)-(6-methoxy-4-pyrimidinyl)-; SMR000036718; SR-01000000177; [(4-aminophenyl)sulfonyl](6-methoxypyrimidin-4-yl)amine; Prestwick_105; Spectrum_001414; Prestwick0_000823; Prestwick1_000823; Prestwick2_000823; Prestwick3_000823; Spectrum2_001421; Spectrum3_000913; Spectrum4_001012; Spectrum5_000985; Oprea1_147724; SCHEMBL93784; BSPBio_000745; KBioGR_001503; KBioSS_001894; 5-25-12-00493 (Beilstein Handbook Reference); MLS000069737; MLS000079369; ARONIS23882; DivK1c_000949; SPECTRUM1501147; SPBio_001522; SPBio_002666; BPBio1_000821; CHEMBL462990; DTXSID8045351; CTK7B2176; HMS502P11; KBio1_000949; KBio2_001894; KBio2_004462; KBio2_007030; KBio3_001886; KS-00000YZZ; ZINC49137; BBC/161; NINDS_000949; HMS1570F07; HMS1921J21; HMS2092H07; HMS2097F07; HMS3714F07; Pharmakon1600-01501147; Ro43476; HY-B0946; KS-000046QL; ZX-AS004378; Sulfamonomethoxine (JAN/USAN/INN); Tox21_110502; BBL023014; CCG-38995; MFCD00063466; NSC757862; s3644; SBB001134; STL089636; AKOS000308735; Tox21_110502_1; CS-4419; MCULE-7069712858; NSC-757862; IDI1_000949; NCGC00016572-02; NCGC00016572-03; NCGC00016572-04; NCGC00016572-05; NCGC00016572-06; NCGC00016572-07; NCGC00016572-08; NCGC00016572-12; NCGC00023060-04; NCGC00023060-05; AC-14922; AK468616; AS-70089; CC-34593; N-(6-Methoxy-4-pyrimidinyl)sulfanilamide; O348; ST007533; SBI-0051659.P002; BB0293573; DB-041649; LS-147813; AB00052221; FT-0633498; S0592; T7351; C12540; D01141; Sulfamonomethoxine 1000 microg/mL in Methanol; AB00052221-12; AB00052221_14; 220S833; A804842; C-17634; J-004759; J-524311; SR-01000000177-3; SR-01000000177-4; BRD-K14116214-001-04-7; BRD-K14116214-001-07-0; Q27114805; Sulfamonomethoxine, VETRANAL(TM), analytical standard; 4-amino-N-(6-methoxy-pyrimidin-4-yl)-benzenesulfonamide; 4-azanyl-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide; 4-AMINO-N-(6-METHOXY-4-PYRIMIDINYL)-BENZENESULFONAMIDE; K4Y; Sulfamonomethoxine; 5-25-12-00493 (Beilstein Handbook Reference)
4-Bromobenzyl alcohol 4-Bromobenzenemethanol; 4-Bromobenzyl alcohol; CCRIS 5119
4-Epianhydrotetracycline (4R,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide; 4-Epianhydrotetracycline; (4R-(4alpha,4abeta,12abeta))-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-2-naphthacenecarboxamide
4-Hydroxybenzoic acid Acido p-idrossibenzoico [Italian]
4-Hydroxycoumarin 4-Hydroxycoumarin; 1076-38-6; 4-Hydroxy-2H-chromen-2-one; 4-Coumarinol; Benzotetronic acid; 2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-; Coumarin, 4-hydroxy-; 4-hydroxychromen-2-one; 4-Hydroxy-2H-1-benzopyran-2-one; 4-Hydroxy-chromen-2-one; 4-hydroxy-2-chromenone; UNII-X954ZLL2RD; 2-Hydroxychromone; 4-Hydroxycoumarine; MFCD00006856; 4-HYDROXY-1-BENZOPYRAN-2-ONE; 4-hydroxy-2H-benzo[b]pyran-2-one; EINECS 214-060-2; NSC 11889; 4-Hydroxycoumarin, 98%; 4H-1-Benzopyran-4-one, 2-hydroxy-; BRN 0129768; X954ZLL2RD; AI3-52393; CHEMBL301141; 22105-09-5; CHEBI:40070; VXIXUWQIVKSKSA-UHFFFAOYSA-N; NSC11889; 4-hydroxy-coumarin; 4-Hydroxy coumarin; hydroxychromone; 4-hyroxycoumarin; 4- Hydroxycoumarin; 4-hydroxyl coumarin; 4-Monohydroxycoumarin; PubChem8693; ACMC-1BO7V; CBiol_000838; WLN: T66 BOVJ EQ; 5-18-01-00378 (Beilstein Handbook Reference); KSC175M9D; MLS004491719; SCHEMBL131312; Coumarin, 4-hydroxy- (8CI); MEGxm0_000452; SCHEMBL1961365; DTXSID8061472; ACon1_001952; CTK0H5691; 4-Hydroxy-2H-chromen-2-one #; DTXSID50944748; HMS1607G02; 4-hydroxy-2-oxo-2H-1-benzopyran; 2-Hydroxy-4H-1-benzopyran-4-one; BCP31120; HY-N6856; STR01861; ANW-15833; BBL027616; BDBM50055710; ICCB4_000134; NSC-11889; SBB038533; STK801816; ZINC18154848; ZINC96006086; AKOS000119142; AKOS037515220; AM84328; DB03410; EBD2035794; LS40467; MCULE-5951606896; RTC-020138; TRA-0204940; NCGC00179970-01; 4HC; AC-13227; AK-49238; LS-39686; NCI60_000453; SC-00282; SMR000112320; SY001614; AB0004657; DB-014485; ST2418405; TC-020138; BB 0220623; CS-0015925; EU-0066799; FT-0602218; FT-0660645; ST50211285; A-9316; C20414; 4-Hydroxycoumarin, Vetec(TM) reagent grade, 98%; SR-01000389319; J-515519; J-620003; SR-01000389319-1; 4-Hydroxy-2H-1-benzopyran-2-one (4-Hydroxycoumarin); BRD-K48844111-001-01-4; Q25323691; Z56922074; 4-HYDROXY-1-BENZOPYRAN-2-ONE; 4-HYDROXYCOUMARIN; F0266-2972; 4-Hydroxy Coumarin; 4-Coumarinol; 4-Hydroxy-2H-chromen-2-one; InChI=1/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10; 5-18-01-00378 (Beilstein Handbook Reference)
4-Methyl-1,2-benzenediol 4-Methylcatechol; 452-86-8; 4-methylbenzene-1,2-diol; 3,4-Dihydroxytoluene; Homocatechol; p-Methylcatechol; 4-Methyl-1,2-benzenediol; 4-METHYLPYROCATECHOL; Homopyrocatechol; 1,2-Dihydroxy-4-methylbenzene; p-Methylpyrocatechol; Toluene-3,4-diol; 1,2-Benzenediol, 4-methyl-; 4-Methyl-1,2-dihydroxybenzene; Pyrocatechol, 4-methyl-; 2-Hydroxy-4-methylphenol; UNII-12GLI7JGB3; NSC 17489; CCRIS 3333; CHEBI:17254; EINECS 207-214-5; BRN 0636512; 12GLI7JGB3; 1-Methyl-3,4-dihydroxybenzene; ZBCATMYQYDCTIZ-UHFFFAOYSA-N; 4-Methylcatechol, 98%; 5-methylcatechol; 4-Methylcatehol; 4-Metylcatechol; 4-methyl catechol; 4-methyl-catechol; 4-methyl pyrocatechol; 4-methyl-Pyrocatechol; 4k7n; DSSTox_CID_861; ACMC-209k1x; bmse000475; Epitope ID:150928; DSSTox_RID_75831; 4-methyl-benzene-1,2-diol; DSSTox_GSID_20861; SCHEMBL12388; 4-Methylcatechol, >=95%; KSC490K8N; MLS001066329; 4-Methylbenzene-1,2-diol #; 1,2-dihydroxy-5-methylbenzene; CHEMBL158766; DTXSID5020861; 4-methyl-1,2-dihydroxy benzene; CTK3J0586; KS-00000JE6; NSC17489; Tox21_200632; ANW-30259; c0126; MFCD00002205; NSC-17489; s5616; SBB061372; ZINC13512210; AKOS000121479; 1,2-Benzenediol, 4-methyl- (9CI); AS07054; CS-W013530; DB04120; HY-W012814; LS-1269; MCULE-3649506114; RTR-032979; TRA0071015; NCGC00248773-01; NCGC00258186-01; AC-12438; AK163402; AS-11944; CAS-452-86-8; SC-46405; SMR000471857; AB0011051; DB-051291; TR-032979; FT-0618974; M0413; ST24043912; ST51047392; AZ0001-0502; C06730; W-106144; Q15303189; F0001-1227; InChI=1/C7H8O2/c1-5-2-3-6(8)7(9)4-5/h2-4,8-9H,1H; 4-Methylcatechol; 4-06-00-05878 (Beilstein Handbook Reference)
4-Methyl-2-nitrophenol 2-Nitro-p-cresol; 4-Methyl-2-nitrophenol; 119-33-5; 2-NITRO-P-CRESOL; Phenol, 4-methyl-2-nitro-; o-Nitro-p-cresol; 2-Nitro-4-methylphenol; 4-Hydroxy-3-nitrotoluene; 2-Nitro-4-cresol; p-Cresol, 2-nitro-; 4-METHYL-2-NITRO-PHENOL; UNII-P92KPK2NL3; NSC 5387; EINECS 204-315-6; MFCD00007120; BRN 1868022; P92KPK2NL3; AI3-15389; 4-Methyl-2-nitrophenol, 99%; SYDNSSSQVSOXTN-UHFFFAOYSA-N; WLN: WNR BQ E1; 12167-20-3; Methylnitrophenol; 2-nitro p-cresol; 3(OR 4)-METHYL-2-NITROPHENOL; PubChem12745; 4-methyl-2-nitro phenol; ACMC-1B7GH; DSSTox_CID_6961; DSSTox_RID_78268; DSSTox_GSID_26961; 4-06-00-02149 (Beilstein Handbook Reference); KSC490K8H; SCHEMBL306096; CHEMBL1234658; DTXSID0026961; CTK3J0583; NSC5387; KS-00000VR2; NSC-5387; NSC66511; STR03111; Tox21_200933; ANW-17316; NSC-66511; SBB058864; STK399771; ZINC20230664; AKOS001094378; DB04110; MCULE-4558023540; PS-4598; RTR-003253; TRA0060302; NCGC00248879-01; NCGC00258487-01; 68137-08-6; AC-11583; CAS-119-33-5; LS-55428; P640; DB-041464; TR-003253; 4-Methyl-2-nitrophenol (2-Nitro-p-cresol); FT-0619011; N0186; ST24029165; ST50585953; W-108517; Q27094955; InChI=1/C7H7NO3/c1-5-2-3-7(9)6(4-5)8(10)11/h2-4,9H,1H; 2-Nitro-4-cresol; 4-06-00-02149 (Beilstein Handbook Reference)
4-Methylimidazole 1H-IMIDAZOLE, 4-METHYL-; 4-Methylimidazole; AI3-08274
4-Nitrophenylacetic acid p-Nitrophenylacetic acid; AI3-15093
4-Phenylbutyric acid Benzenebutanoic acid; 4-Phenylbutyric acid; AI3-12065
4-Trifluoromethylphenol 4-(Trifluoromethyl)phenol; 4-(Trifluoromethyl)phenol; 402-45-9; 4-Hydroxybenzotrifluoride; 4-Trifluoromethylphenol; alpha,alpha,alpha-Trifluoro-p-cresol; p-trifluoromethylphenol; Phenol, 4-(trifluoromethyl)-; a,a,a-Trifluoro-p-cresol; p-Hydroxybenzotrifluoride; 4-(Trifluoromethyl)-phenol; para-trifluoromethylphenol; 4-Hydroxy-alpha,alpha,alpha-trifluorotoluene; CHEBI:42578; BAYGVMXZJBFEMB-UHFFFAOYSA-N; p-(Trifluoromethyl)phenol radical cation; .alpha.,.alpha.,.alpha.-Trifluoro-p-cresol; FCR; 4-(Trifluoromethyl)phenol, 98%; 73073-69-5; 4-trifluoromethyl-phenol; EINECS 206-945-7; MFCD00002363; NSC 88303; 4-trifluoromethyphenol; PubChem4011; 4-trifiuoromethylphenol; 4-trifluromethyl-phenol; 4-trifluoromethyl phenol; AI3-26185; 4-hydroxybenzotri-fluoride; 4-(trifluormethyl)-phenol; p-(trifluoromethyl)-phenol; A,a,a-trifluoro-4-cresol; ACMC-209jc7; 4-(trifluoromethyl) phenol; SCHEMBL57109; 4-(Trifluoromethyl)phenol #; KSC235O3F; CHEMBL539165; DTXSID2075392; BAYGVMXZJBFEMB-UHFFFAOYSA-; CTK1D5732; 4-(trifluoromethyl)phenyl alcohol; SR-1C13; 4-(Trifluoromethyl)phenol, 97%; ACN-S003386; ACT00240; NSC88303; ZINC1847459; ANW-29333; CCG-40536; NSC-88303; AKOS000121599; AC-2562; AS-8193; AS01417; CM11811; CS-W001935; DB03610; EBD2201955; LF10170; LS10322; MCULE-3925033033; RTC-030398; TRA0057121; KS-0000098J; BETA,BETA,BETA-TRIFLUORO-P-CRESOL; BP-12755; BR-40084; SC-04273; AB0011109; AB1002338; DB-006569; ST2411048; TC-030398; A6731; ALPHA,ALPHA,ALPHA-TRIFLUORO-4-CRESOL; AM20060195; FT-0600891; ST50406639; EN300-16616; A-1977; 16301-EP2281563A1; 16301-EP2316459A1; 402H459; W-106373; Q27094528; Z56347220; F0001-1137; InChI=1/C7H5F3O/c8-7(9,10)5-1-3-6(11)4-2-5/h1-4,11H; 4-Trifluoromethylphenol; AI3-26185
5,6-Dihydroxyindole 1H-Indole-5,6-diol; 5,6-Dihydroxyindole; 3131-52-0; 1H-Indole-5,6-diol; Dopamine lutine; 3H-INDOLE-5,6-DIOL; dhi; UNII-Z3OC8499KG; C8H7NO2; CHEMBL92636; Z3OC8499KG; CHEBI:27404; AK-25753; D-3560; 5,6-DihydroxyindoleI; 5,6-Dihydroxy-1H-indole; indole-5,6-diol; 5,6-dihydroxy indole; EC 412-130-9; SCHEMBL48994; CTK1C3371; DTXSID20185242; SGNZYJXNUURYCH-UHFFFAOYSA-N; ZINC895800; ACT06797; BCP02562; EBD26988; KS-00000J9K; ZX-AT011826; ANW-44822; BBL102959; BDBM50028548; CD-595; FCH834612; MFCD00798933; STL556768; AKOS005258825; CS-W018811; DB01811; LS20632; OR40006; AC-22682; DS-10556; AX8020151; DB-008889; LS-174334; TR-013324; 4CH-009846; A5673; FT-0600101; ST24029241; Z1653; A-8886; C05578; Q9207472; InChI=1/C8H7NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9-11; 5,6-Dihydroxyindole; Dopamine lutine
5,6-Dimethylbenzimidazole 5,6-Dimethyl-1H-benzimidazole; 5,6-Dimethylbenzimidazole; 582-60-5; 5,6-dimethyl-1H-benzo[d]imidazole; Dimedazol; Dimedazole; Dimesol; 5,6-Dimethyl-1H-benzimidazole; Dimezol; 1H-Benzimidazole, 5,6-dimethyl-; dimethylbenzimidazole; 5.6-Dimethylbenzimidazole; Benzimidazole, 5,6-dimethyl-; NSC 68316; UNII-553XI1DS20; 5,6-dimethyl-1H-benzoimidazole; 5,6-dimethylbenzimidazol; EINECS 209-488-1; MFCD00005603; BRN 0116595; AI3-52806; CHEMBL351132; CHEBI:15890; LJUQGASMPRMWIW-UHFFFAOYSA-N; 553XI1DS20; 5,6-dimethyl-1H-1,3-benzodiazole; 5,6-Dimethylbenzimidazole, 99+%; 5,6-Dimethyl Benzimidazole; DimezolDimedazol; Dimezol base; Dimezol (VAN); PubChem7550; ACMC-1ALRI; Benzimidazole,6-dimethyl-; 5,6-dimethylbenzoimidazole; bmse000881; 5-23-06-00454 (Beilstein Handbook Reference); KSC269G6H; SCHEMBL312977; 1H-Benzimidazole,6-dimethyl-; 5,6-dimethylbenzo[d]imidazole; ARONIS001284; SCHEMBL3893948; CTK1G9363; KS-00000JIQ; DTXSID70870631; HMS1659L03; ZINC388593; ALBB-021295; KS-00003US8; NSC68316; 5,6-Dimethylbenzimidazole, >=99%; ANW-32902; BBL023511; BDBM50208872; NSC-68316; SBB004105; STK001228; 5,6-dimethyl-1H-1,3-benzimidazole; AKOS000121551; AC-8359; CS-W018227; DB02591; HY-W017511; MCULE-3421723513; RTR-033372; VI10159; TRA-0184678; AK-78911; AS-10901; LS-32891; SC-05507; TR-033372; AM20040774; BB 0241929; D1345; FT-0619833; ST24023685; ST45038102; C03114; L-1289; AB00375938-02; 5,6-Dimethylbenzimidazole, purum, >=99.0% (NT); Q-100667; Q15269676; F3145-1021; B97E9041-BA87-4952-8BE7-E80B4E480262; InChI=1/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11; 5,6-Dimethylbenzimidazole; 5-23-06-00454 (Beilstein Handbook Reference)
5-(Hydroxymethyl)-2-furancarboxaldehyde 5-HYDROXYMETHYLFURFURAL; 67-47-0; 5-Hydroxymethyl-2-furaldehyde; 5-(hydroxymethyl)furan-2-carbaldehyde; 5-(Hydroxymethyl)furfural; 5-(Hydroxymethyl)-2-furaldehyde; Hydroxymethylfurfural; 5-(Hydroxymethyl)-2-furfural; 5-Oxymethylfurfurole; 5-Hydroxymethylfuraldehyde; Hydroxymethylfurfurole; 5-Hydroxymethylfuran-2-aldehyde; Hydroxymethylfurfuraldehyde; Hydroxymethylfurfuralaldehyde; 2-Hydroxymethyl-5-furfural; 2-Furancarboxaldehyde, 5-(hydroxymethyl)-; 5-Hydroxymethyl-2-formylfuran; 5-(Hydroxymethyl)-2-furancarbonal; 5-(Hydroxymethyl)-2-furfuraldehyde; 5-Hydroxymethylfurfuraldehyde; 5-(Hyddroxymethyl)furfurole; 5-Hydroxymethyl-2-furfural; 5-(Hydroxymethyl)-2-furancarboxaldehyde; 5-hydroxymethyl furfural; 5-Hydroxymethyl-2-furancarboxaldehyde; 5-HYDROXYMETHYL-FURFURAL; HMF; 2-Furaldehyde, 5-(hydroxymethyl)-; 5-(Hydroxymethyl)furan-2-aldehyde; 5-Hydroxymethyl-2-furancarbaldehyde; 5-HMF; UNII-70ETD81LF0; MFCD00003234; NSC 40738; CCRIS 3160; CHEBI:412516; EINECS 200-654-9; 5-(Hydroxymethyl)furfurole; BRN 0110889; 70ETD81LF0; 5-(Hydroxymethyl)-2-formylfuran; NOEGNKMFWQHSLB-UHFFFAOYSA-N; 5-Hydroxymethyl-furan-2-carbaldehyde; NSC-40738; DSSTox_CID_10428; DSSTox_RID_78848; DSSTox_GSID_30428; 5-(Hydroxymethyl)furfural, 98%; CAS-67-47-0; Aes 103; Aes-103; 5-Hydroxymethyl-2-furfuraldehyde; HSDB 7982; 5-methylolfurfural; 5-(Hydroxymethyl)furan-2-carboxaldehyde; 5-hydromethyl-furfural; 5-Hydrxoymethylfurfural; 5-formylfurfuryl alcohol; 5-hydroxy methyl furfural; ACMC-1BG6F; Epitope ID:136033; 5-Hydroxymethyl furaldehyde; CBiol_000485; SCHEMBL19176; 5-18-01-00130 (Beilstein Handbook Reference); KSC495A5B; MLS002454379; 2-formyl-5-hydroxymethylfuran; CHEMBL185885; QSPL 022; DTXSID3030428; CTK3J5050; ZINC900788; 5-hydroxymethylfuran-2-carbaldehyde; ACN-S003116; BCP31207; CS-D1116; HY-Y0051; NSC40738; Tox21_201892; Tox21_303551; ANW-35343; BBL100102; CH-667; GEO-01528; ICCB3_000133; s3772; SBB004259; STL451297; 5-Hydroxymethyl-2-furaldehyde, 99%; 5-(hydroxymethyl)-2-furfural (HMF); AKOS005166879; AC-1262; DB12298; GS-3074; LS-1562; MCULE-9029574240; RTR-022657; TRA0042696; 5-(hydroxymethyl)-furan-2-carbaldehyde; NCGC00091513-01; NCGC00091513-02; NCGC00257266-01; NCGC00259441-01; 4CN-0758; 5-(hydroxymethyl)-2-furan-carboxaldehyde; 5-(Hydroxymethyl)furfural, >=99%, FG; AK-26249; BR-26249; L782; SC-22154; SMR000393981; ST056380; SY010869; 5-(hydroxy methyl) 2-furan-carboxaldehyde; AB0007209; DB-007058; ST2411674; TR-022657; A9037; AM20100616; FT-0080682; FT-0600483; N1335; EN300-82764; 5-(Hydroxymethyl)furfural, analytical standard; 67H470; C11101; Q414606; Q-200545; F2191-0155; Z1741972784; InChI=1/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H; 5-Hydroxymethylfurfural; 5-18-01-00130 (Beilstein Handbook Reference)
5-Aminouracil 5-Aminouracil; 932-52-5; 5-aminopyrimidine-2,4(1H,3H)-dione; 5-Amino-2,4-dihydroxypyrimidine; 5-AMINO-1H-PYRIMIDINE-2,4-DIONE; URACIL, 5-AMINO-; 2,4(1H,3H)-Pyrimidinedione, 5-amino-; 2,4-Dihydroxy-5-aminopyrimidine; UNII-R2O7EKY9G9; 5-aminopyrimidine-2,4-diol; 5-Aminouracil, 98%; EINECS 213-252-3; MFCD00006025; NSC 22474; R2O7EKY9G9; AI3-50678; BISHACNKZIBDFM-UHFFFAOYSA-N; 5-amino uracil; WBU; ACMC-209rks; 5-amino-1,3-dihydropyrimidine-2,4-dione; SCHEMBL65085; Uracil, 5-amino- (VAN); 2,4-dioxo-5-aminopyrimidine; CHEMBL1236704; DTXSID1061312; CTK3J2926; 2,3H)-Pyrimidinedione, 5-amino-; NSC22474; ZINC1236370; 5-azanyl-1H-pyrimidine-2,4-dione; ANW-40010; BBL011353; KM3177; NSC-22474; STL146443; Uracil, 5-amino- (VAN) (8CI); AKOS001603829; AM83915; DB03792; MCULE-8766220931; 4-Amino-2,6-dihydroxypyrimidine, 97%; AK-68403; AS-11275; BP-30253; SC-09022; SY035728; 5-Amino-2,4(1H,3H)-pyrimidinedione #; DB-002590; LS-158541; A0898; FT-0620029; ST50186514; 16436-EP2281563A1; 16436-EP2316459A1; 932A525; A844487; J-800160; Q27094684; F3096-1977; InChI=1/C4H5N3O2/c5-2-1-6-4(9)7-3(2)8/h1H,5H2,(H2,6,7,8,9; AI3-50678
5-Chloro-2-methyl-4-isothiazolin-3-one 5-Chloro-2-methyl-3(2H)isothiazolone; 5-Chloro-2-methyl-4-isothiazolin-3-one; BRN 1210149
5-Fluorouracil 5-Fluoro-2,4(1H,3H)pyrionidinedione; Fluorouracil [USAN:USP:INN:BAN:JAN]; U-8953
5-Fluorouridine 5-Fluorouridine; 316-46-1; 5-Fur; Uridine, 5-fluoro-; 5-Fluoro-uridine; 5-Fluorouracil 1beta-D-ribofuranoside; UNII-4K0M952561; EINECS 206-260-3; NSC 146604; BRN 0033662; CHEMBL54918; FUrd; CHEBI:40154; FHIDNBAQOFJWCA-UAKXSSHOSA-N; 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione; 77180-80-4; 4K0M952561; fluorouridine; C9H11FN2O6; Fur; 1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,3-dihy dropyrimidine-2,4-dione; 5UD; 5-fluoro-d-uridine; beta-D-5FdU; MFCD00036832; PubChem21063; 4pb2; cid_1821; SCHEMBL53091; 4-24-00-01231 (Beilstein Handbook Reference); KSC223Q4T; BIDD:GT0496; GTPL4614; DTXSID4040397; CTK1C3849; PC4380B; 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-pyrimidine-2,4-dione; AFU; ZINC1078624; ZX-AP011701; ANW-27173; BDBM50132299; CF-071; AKOS015852922; AKOS015918304; 5-Fluorouracil 1-.beta.-D-arabinosyl; DB01629; LS40592; 5-Fluorouridine, >=99.0% (HPLC); NCGC00142485-01; NCGC00142485-02; NCGC00142485-03; 5-Fluoro-1-.beta.-D-ribofuranosyluracil; AS-13467; CC-21810; I377; SC-48166; ST056943; AB0013656; AX8011282; DB-005381; HY-107856; LS-160834; CS-0030739; FT-0600892; FT-0692734; C16633; J10413; 16510-EP2281563A1; 16510-EP2316459A1; 180F804; C-16378; J-700089; Q27073979; 1-.beta.-D-Arabinofuranosyl-5-fluoro-(1H,3H)-pyrimidine-2,4-dione; 2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-fluoro-; 5-Fluorouridine, proapoptotic anitproliferative plant growth regulator; 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione; 1-((2R,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione; 1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione(5F-dUrd); 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione; 4-24-00-01231 (Beilstein Handbook Reference)
5-Methylbenzimidazole 5-Methyl-1H-benzimidazole; 5-Methylbenzimidazole; 614-97-1; 5-methyl-1H-benzo[d]imidazole; 5-methyl-1H-benzimidazole; 1H-Benzimidazole, 5-methyl-; 6-methyl-1H-benzimidazole; BENZIMIDAZOLE, 5-METHYL-; 1H-Benzimidazole, 6-methyl-; NSC 3826; EINECS 210-401-4; UNII-R56855UC8Y; CHEMBL157729; 5-methyl-1H-1,3-benzodiazole; 6-methyl-1H-1,3-benzodiazole; CHEBI:40205; RWXZXCZBMQPOBF-UHFFFAOYSA-N; R56855UC8Y; MFCD00010740; ethyl 4-cyanophenylalaninate; 6-Methylbenzimidazol; 5-methylbenzoimidazole; PubChem7666; ACMC-1BEHW; 5(6)-Methylbenzimidazole; 5-methyl-1H-benzoimidazole; SCHEMBL10903; 5-Methylbenzimidazole, 98%; BIDD:GT0671; DTXSID1060639; CTK3J3270; WLN: T56 BM DNJ G1; NSC3826; Benzimidazole, 5(or 6)-methyl-; ALBB-028791; NSC-3826; ZINC5988533; ANW-33835; ANW-45816; BBL015760; BDBM50208880; SBB046249; STK242092; phenylalanine, 4-cyano-, ethyl ester; AKOS000275603; AKOS015953401; AC-2010; ACN-050882; DB03177; GS-6306; MCULE-9032121446; VI10184; 5MB; AK-87161; Benzimidazole, 5(or 6)-methyl- (7CI); LS-33045; O736; SY037745; AB1008119; DB-017454; RT-001370; ST2418817; TC-134561; 4CH-014716; BB 0219447; FT-0620642; M1321; ST45021926; L-4171; 614M971; W-105148; Q27094112; F2163-0011; InChI=1/C8H8N2/c1-6-2-3-7-8(4-6)10-5-9-7/h2-5H,1H3,(H,9,10; 5-Methylbenzimidazole; 1H-Benzimidazole, 5-methyl-
5-Nitroindazole 5-Nitro-1H-indazole; 5-Nitroindazole; 5-Nitro-1H-indazole; 5401-94-5; 1H-INDAZOLE, 5-NITRO-; UNII-235Y7P37ZD; CCRIS 4134; NSC 5032; EINECS 226-451-5; BRN 0007936; CHEMBL165372; WSGURAYTCUVDQL-UHFFFAOYSA-N; 235Y7P37ZD; MFCD00005693; 5NI; 2H-Indazole, 5-nitro-; 5-Nitroindazol; 5-nitro indazole; 5-nitro-indazole; 5-nitro-1H-indazol; 5-nitro-IH-indazole; 5-nitro-2H-indazole; PubChem15672; 4lm0; ACMC-209lc9; 5-Nitroindazole, >=99%; DSSTox_CID_29272; DSSTox_RID_83391; DSSTox_GSID_49316; 5-23-06-00180 (Beilstein Handbook Reference); KSC490O7N; MLS000728712; SCHEMBL148826; DTXSID5049316; SCHEMBL17594510; CTK3J0776; NSC5032; HMS2699L04; HMS3604H19; ZINC156104; ACT06347; BCP23472; CS-B1273; KS-000003YS; NSC-5032; Tox21_202925; ANW-31927; BDBM50304144; CN-037; SBB002561; STK764725; AKOS000120077; AKOS015966034; AKOS024268503; AC-2732; DB04534; MCULE-9111482594; PB25890; RTC-063955; VI20057; WT82102; NCGC00245898-01; NCGC00260471-01; 65750-01-8; AK-27901; AS-11700; BR-27901; LS-81534; SC-16543; SMR000306991; CAS-5401-94-5; AB1001429; DB-014603; ST2412116; ST4097030; TC-063955; A7852; AM20040676; FT-0602362; N0398; Q-1003; 118505-EP2295412A1; 118505-EP2295413A1; 118505-EP2298767A1; 126814-EP2295412A1; 126814-EP2295413A1; A829911; AQ-776/40649175; Q-200548; Q27253724; Z57471016; F0001-1417; InChI=1/C7H5N3O2/c11-10(12)6-1-2-7-5(3-6)4-8-9-7/h1-4H,(H,8,9; 5-Nitroindazole; 5-23-06-00180 (Beilstein Handbook Reference)
5-Phenylvaleric acid Benzenepentanoic acid; 5-Phenylvaleric acid; 4-09-00-01864 (Beilstein Handbook Reference)
5alpha-Androstane-3alpha,17beta-diol (3alpha,5alpha,17beta)-Androstane-3,17-diol; Hombreol; 3alpha-androstanediol; 5alpha-Androstane-3alpha,17beta-diol; 1852-53-5; 3alpha,17beta-Dihydroxy-5alpha-androstane; Dihydroandrosterone; Etiocholane-3alpha,17beta-diol; NSC 9899; UNII-J34MX0M30Y; 5alpha-Androstan-3alpha,17beta-diol; 5a-Androstane-3a,17b-diol; 3alpha androstanediol; 5alpha-Androstane-3alpha,17beta-androstanediol; EINECS 217-447-4; (3alpha,5alpha,17beta)-androstane-3,17-diol; BRN 2694353; MLS000028362; CHEMBL335062; J34MX0M30Y; 5-alpha-ANDROSTANE-3-alpha,17-beta-DIOL; CHEBI:36713; 3-alpha,17-beta-Dihydroxy-5-alpha-androstane; Androstane-3,17-diol, (3-alpha,5-alpha,17-beta)-; SMR000058611; Androstan-3alpha,17beta-diol; ANDROSTANDIOL; 5.alpha.-Androstane-3.alpha.,17.beta.-diol; 3a-androstanediol; 5 alfa-Androstane-3beta, 17beta-diol; Androstane-3a,17b-diol; Opera_ID_1641; 17beta-dihydroandrosterone; Etiocholane-3a,17b-diol; (3.alpha.,5.alpha.,17.beta.)-Androstane-3,17-diol; 3a,5a-Tetrahydrotestosterone; 4-06-00-06097 (Beilstein Handbook Reference); MLS000563089; BIDD:ER0064; SCHEMBL869146; 3-alpha,17-beta-Androstanediol; DTXSID3022378; NIOSH/BV8044300; 3a,17b-Dihydroxy-5a-androstane; TQP0569; Androstane-3-alpha,17-beta-diol; CBMYJHIOYJEBSB-KHOSGYARSA-N; HMS2236G09; (3R,5S,8R,9S,10S,13S,14S,17S)-10,13-Dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol; ZINC3814411; BDBM50093445; LMST02020052; MFCD00003676; 5-alpha-androstan-3alpha,17beta-diol; AKOS015960923; DB01530; AC-12630; LS-19354; BV80443000; 5Alpha-androstane-3alpha pound not17beta-diol; 5alpha-Androstane-3alpha,17beta-diol (8CI); C03852; 852A535; Androstane-3,17-diol, (3alpha,5alpha,17beta)-; C-18356; Q6590364; W-107784; Androstane-3,17-diol, (3alpha,5alpha,17beta)- (9CI); (3R,5S,8R,10S,13S,17S)-10,13-Dimethyl-hexadecahydro-cyclopenta[a]phenanthrene-3,17-diol; 3alpha-Androstanediol; 4-06-00-06097 (Beilstein Handbook Reference)
5alpha-Androstane-3beta,17beta-diol (3beta,5alpha,17beta)-Androstane-3,17-diol; 3beta-androstanediol; 571-20-0; 5alpha-Androstane-3beta,17beta-diol; (3beta,5alpha,17beta)-androstane-3,17-diol; 3beta androstanediol; UNII-6J0K4253QD; 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL; 5a-Androstane-3b,17b-diol; 3beta,17beta-Dihydroxy-5alpha-androstane; CHEBI:18329; CBMYJHIOYJEBSB-YSZCXEEOSA-N; 3.beta.,17.beta.-Androstanediol; 6J0K4253QD; 5alpha-Androstan-3beta,17beta-diol; 5alpha-Androstane-3b,17b-diol; 3.beta.,17.beta.-Dihydroxy-5.alpha.-androstane; Androstanediol; 3-beta,17-beta-Androstanediol; 3beta,17beta-Androstanediol (VAN); EINECS 209-334-3; ANDROSTANDIOL; NSC 50891; BRN 2559488; 5-alpha-ANDROSTANE-3-beta,17-beta-DIOL; 3-beta,17-beta-Dihydroxy-5-alpha-androstane; 5.alpha.-Androstane-3.beta.,17.beta.-diol; Androstane-3,17-diol #; 5|A-androstane-3|A,17|A-diol; 3b,17b-Androstanediol; (3.beta.,5.alpha.,17.beta.)-Androstane-3,17-diol; Androstan-3beta,17beta-diol; 4-06-00-06096 (Beilstein Handbook Reference); BIDD:ER0165; SCHEMBL867704; 5a-an-drostane-3b,17b-diol; CHEMBL316048; DTXSID8022379; 3b,17b-Dihydroxy-5a-androstane; TQP0570; Androstane-3,17-diol, (3-beta,5-alpha,17-beta)- (9CI); (3S,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol; NSC50891; ZINC3814412; LMST02020053; NSC-50891; 5-alpha-androstan-3beta,17beta-diol; AKOS015964921; API0001492; DB03882; SC-81189; DB-026318; 5alpha-Androstane-3beta,17beta-diol (8CI); C12525; Androstane-3, (3.beta.,5.alpha.,17.beta.)-; 571A200; C-18358; Q4641516; W-105485; (3alpha,5beta,8alpha,17beta)-androstane-3,17-diol; Androstane-3,17-diol, (3beta,5alpha,17beta)- (9CI); (3S,5S,8R,10S,13S,17S)-10,13-Dimethyl-hexadecahydro-cyclopenta[a]phenanthrene-3,17-diol; 3beta-Androstanediol; 4-06-00-06096 (Beilstein Handbook Reference)
6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione 6,7-Dinitro-2,3-quinoxalinediol; dnqx; 2379-57-9; 6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione; FG 9041; FG-9041; UNII-62T278S1MX; 6,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione; 6,7-Dinitroquinoxaline-2,3-dione (DNQX); 2,3-Quinoxalinedione, 1,4-dihydro-6,7-dinitro-; 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione; 62T278S1MX; SR-01000075442; 1ftl; Tocris-0189; Lopac-D-0540; Biomol-NT_000182; Lopac0_000345; Oprea1_127694; MLS000705107; SCHEMBL594575; BPBio1_001176; C8H4N4O6; CHEMBL155265; SCHEMBL8128055; CHEBI:93492; CTK8F7031; DTXSID60178476; 6,7-dinitro-2,3-quinoxalinediol; 6,7-dinitroquinoxaline-2,3-diol; HMS2599K21; HMS3261E11; HMS3266C03; HMS3411A15; HMS3675A15; DNQX, >=98% (TLC); Tox21_500345; BN0195; MFCD00069257; STL431184; STL507389; ZINC18118278; AKOS000448016; AKOS005066561; CCG-204440; CS-5935; DB03759; LP00345; MCULE-3076221110; SDCCGSBI-0050333.P002; NCGC00015319-01; NCGC00015319-02; NCGC00015319-03; NCGC00015319-04; NCGC00015319-05; NCGC00015319-06; NCGC00024490-01; NCGC00024490-02; NCGC00024490-03; NCGC00024490-04; NCGC00261030-01; AS-55799; HY-15067; SMR000230466; ST044512; ZINC000018118278; LS-143032; EU-0100345; FT-0620868; KS-00001876; A13882; D 0540; 1,4-Dihydro-6,7-Dinitro-2,3-Quinoxalinedione; AE-641/00586054; SR-01000313889; J-015214; SR-01000075442-1; SR-01000075442-3; SR-01000313889-1; BRD-K64400208-001-01-8; BRD-K64400208-001-02-6; BRD-K85266041-304-01-7; FG 9041; 6,7-Dinitroquinoxaline-2,3-dione
6-Carboxymethyluracil Uracil acetic acid; 4-Pyrimidineacetic acid, 1,2,3,6-tetrahydro-2,6-dioxo-; AI3-25481
7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one rel-7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone; Halofuginone; 55837-20-2; Tempostatin; HalofuginoHalofuginonum; Halocur; Halofuginone [INN:BAN]; Halofuginonum [INN-Latin]; Halofuginona [INN-Spanish]; (+/-)-trans-7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone; Halofunginone; 7-Bromo-6-Chloro-3-{3-[(2r,3s)-3-Hydroxypiperidin-2-Yl]-2-Oxopropyl}quinazolin-4(3h)-One; HalocurTM; 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidyl]-2-oxo-propyl]quinazolin-4-one; trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)-quinazolinone; (+)-Halofuginone; HFG; NSC713205; SCHEMBL9541147; CHEMBL1199540; 7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidyl]-2-oxopropyl]-4(3H)-Quinazolinone; 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-((2R,3S)-3-hydroxy-2-piperidinyl)-2-oxopropyl)-, rel-; 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-; 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-(+-)-; ZINC5784191; s8144; AKOS022185424; DB04866; (+-)-trans-7-Brom-6-chlor-3-(3-(3-hydroxy-2-piperidyl)acetonyl-4(3H)-chinazolinon; (+-)-trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)acetonyl-4(3H)-quinazolinone; 4(3H4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, trans-(+/-)-; rel-7-Bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4(3H)-quinazolinone; ST24049332; Q4132745; HALOFUGINONE ((2R,3S) AND (2S,3R) MIXTURE); UNII-L31MM1385E component LVASCWIMLIKXLA-CABCVRRESA-N; (+/-)-trans-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone hydrobromide; 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}-3,4-dihydroquinazolin-4-one; Halofuginone; trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3H)-quinazolinone